The dispute involved Revvity Health Sciences Inc., formerly known as PerkinElmer Health Sciences Inc., a medical diagnostics company, and LabQ Clinical Diagnostics LLC. The case appears to stem from a business dispute between the two diagnostic companies, though the specific underlying claims were not detailed in the summary judgment order.
U.S. District Judge Nathaniel M. Gorton awarded Revvity $6.3 million in damages plus $2.3 million in pre-judgment interest, totaling more than $8.5 million. The judge also granted the company $1.8 million in attorneys' fees and costs. Judge Gorton's order referenced previous memoranda and orders from September 2025 and March 2026, suggesting the case had extensive motion practice leading to the summary judgment ruling.
The case was filed in 2022 and involved both claims and counterclaims between the parties. The summary judgment order appears to be the culmination of nearly four years of litigation, with the court having issued multiple prior rulings on motions in the case before reaching the final damages determination.
The substantial award highlights the significant financial stakes in disputes between medical diagnostics companies. The inclusion of attorneys' fees suggests the case may have involved claims under a contract or statute that provides for fee-shifting, making it a costly loss for LabQ beyond just the underlying damages.